Ignite Creation Date:
2025-12-26 @ 10:32 AM
Ignite Modification Date:
2026-06-25 @ 1:09 AM
Study NCT ID:
NCT01647828
Status:
COMPLETED
Last Update Posted:
2023-02-15
First Post:
2012-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer
Sponsor:
OncoMed Pharmaceuticals, Inc.
Organization: